Beacon Equity Research Featured Company: Viropro International Inc. (VPRO.OB)
Viropro International Inc. (VPRO.OB) is focused on supporting pharmaceutical companies in South America, Asia, Africa and Eastern Europe, by providing them with the opportunity to produce and commercialize therapeutic products of industrial quality at competitive prices within their local area. The unique business strategy utilized by Viropro is primarily based on the acquisition of exclusive products and intellectual property as well as developing key partnerships with pre-eminent entities on a global scale. To date the company has signed agreements with Immuno Japan Inc., the Biotechnological Research Institute of the National Council of Canada, the Laboratory of Veterinary, and Food Biotechnology…